![](https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Pressemitteilungen
Willkommen im Pressebereich. Vertreter:innen der Presse schreiben uns bitte eine E-Mail, um in unseren Medienverteiler aufgenommen zu werden.
Filter Pressemitteilungen:
![](https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/06/20/1003/BRAIN_GoldOre_300dpi_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
![](https://www.brain-biotech.com/sized/press/2018/06/06/1006/Cover-DE_neu_42034f04a3c2f3f0d1f8da9f34a68a33.jpg 795w 596h, https://www.brain-biotech.com/sized/press/2018/06/06/1006/Cover-DE_neu_05ddcb54a8ae57179ced8b1613e77639.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/06/06/1006/Cover-DE_neu_9f1ba948fa4690ad67f56f895a595a5f.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/06/06/1006/Cover-DE_neu_1d69c308f601759cab37417d2aee21e1.jpg 400w 300h)
Geschäftsbericht der BRAIN AG mit European Design Award ausgezeichnet
BRAIN AG erwartet trotz schwachem Halbjahr zweistelliges Umsatzwachstum im Geschäftsjahr 2017/18
![](https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/03/17/1012/Biocatalysts_Building_1_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
BRAIN AG erwirbt Mehrheitsanteile des führenden Spezial-Enzyme-Produzenten Biocatalysts Ltd.
![](https://www.brain-biotech.com/sized/press/2018/03/12/1015/BRAIN_Annual_Report_2015-16_cover_awards_e64595890892ef90bc6e36e9357f6ced.jpg 800w 600h, https://www.brain-biotech.com/sized/press/2018/03/12/1015/BRAIN_Annual_Report_2015-16_cover_awards_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/03/12/1015/BRAIN_Annual_Report_2015-16_cover_awards_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/03/12/1015/BRAIN_Annual_Report_2015-16_cover_awards_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Geschäftsbericht der BRAIN AG mit iF Design Award ausgezeichnet
![](https://www.brain-biotech.com/sized/press/2018/03/08/1018/BRAIN_HV_2018_02_e64595890892ef90bc6e36e9357f6ced.jpg 1049w 787h, https://www.brain-biotech.com/sized/press/2018/03/08/1018/BRAIN_HV_2018_02_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2018/03/08/1018/BRAIN_HV_2018_02_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/03/08/1018/BRAIN_HV_2018_02_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/03/08/1018/BRAIN_HV_2018_02_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
BRAIN AG beendet erfolgreich zweite ordentliche Hauptversammlung seit dem Börsengang
![](https://www.brain-biotech.com/sized/press/2018/03/07/1023/DOLCE_e64595890892ef90bc6e36e9357f6ced.jpg 562w 421h, https://www.brain-biotech.com/sized/press/2018/03/07/1023/DOLCE_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
BRAIN, AnalytiCon Discovery und Roquette erreichen bedeutenden Meilenstein im DOLCE-Programm
![](https://www.brain-biotech.com/sized/press/2018/03/06/1026/BRAIN_LLC_Gebaeude_e64595890892ef90bc6e36e9357f6ced.jpg 1195w 896h, https://www.brain-biotech.com/sized/press/2018/03/06/1026/BRAIN_LLC_Gebaeude_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2018/03/06/1026/BRAIN_LLC_Gebaeude_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2018/03/06/1026/BRAIN_LLC_Gebaeude_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2018/03/06/1026/BRAIN_LLC_Gebaeude_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)